Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Leucovorin. Found 9 abstracts

Marks EI, Brennan M, El-Deiry WS. Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy. 2015 Aug;16(8):1136-9.   PMCID: 4622690
Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology Biology Physics. 2015 Jan;91(1):116-23.   PMCID: 4385459
Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer N. Rectal cancer clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2005 Jul;3(4):492-508.
Langer CJ. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. Lung Cancer. 2001 Nov;34(2):297-303.
Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr;91(7):1256-63.
O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study. J Clin Oncol. 2001 May;19(9):2413-21.
Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol. 2001 Sep 15;19(18):3801-7.
Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001 Oct;61(19):7225-32.
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer. 1999 Jan 15;85(2):290-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Leucovorin

Leucovorin Antineoplastic Combined Chemotherapy Protocols Fluorouracil administration & dosage therapeutic use Male Human analogs & derivatives drug therapy pathology Aged US Gov't Support-PHS Female Camptothecin adverse effects Rectal Neoplasms Oral Administration Non-US Gov't Support Adult mortality Antineoplastic Agents Organoplatinum Compounds Middle Age effects Lung Neoplasms pharmacology Middle Aged Uracil Treatment Outcome Colorectal Neoplasms chemically induced antagonists & inhibitors adverse therapy rt [Radiotherapy] Interferon Alfa-2a Cause of Death Time Factors Drug Administration Schedule Multidrug Resistance-Associated Proteins drug effects dt [Drug Therapy] Neoplasm Metastasis Radiotherapy Dosage methods Randomized Controlled Trials Adenocarcinoma metastatic colorectal adenocarcinoma Animal Guidelines Biological Transport tu [Therapeutic Neoadjuvant Therapy analogs & Cea Radiosurgery Antineoplastic Antimetabolites ATP-Binding Cassette Transporters Methotrexate Prognosis US Gov't Support-Non-PHS administration & 7689-03-4 (Camptothecin) Drug Combinations Vascular Diseases Stomach Neoplasms derivatives Intravenous Infusions Phosphonoacetic Acid Mortality Tegafur Syndrome Carcinoembryonic Antigen Thymidylate Synthase Stomatitis metabolism Folic Acid di [Diagnosis] 0 (Antineoplastic Combined Chemotherapy Protocols) 0 (Organoplatinum Compounds) 58-05-9 (Leucovorin) 0 (Folfox protocol) tumor marker 51-21-8 (Fluorouracil) Multiple Drug Resistance Interferon-alpha Chemoradiotherapy Ca 19-9 3T3 Cells Risk Factors Survival Analysis su [Surgery] Aspartic Acid CA-19-9 Antigen Tritium Disease Progression blood pharmacokinetics 80 and over Aged Lymphatic Metastasis aa [Analogs & Derivatives] Osmolar Concentration Oxidoreductases Polyglutamic Acid Local Neoplasm Recurrence Clinical Trials Neoplasm Staging Deoxycytidine st [Standards] Carcinoma Radiation-Sensitizing Agents Medical Oncology Use] 0 (IFL protocol) Non-Small-Cell Lung Carcinoma Mice tu [Therapeutic Use] Adjuvant Radiotherapy Agranulocytosis Capecitabine Salvage Therapy Enzyme Inhibitors Liver Neoplasms sc [Secondary] Gastrointestinal Diseases dosage Tumor Biomarkers
Last updated on Thursday, April 02, 2020